Hepatology

Professor Trauner introduced the subject of liver disease and its burden within the European Union (EU) and across the globe.

The Synageva BioPharma-sponsored symposium discussed the differential diagnoses for liver diseases that may be under-recognised in clinical settings…

Rapid developments in clinical research on the hepatitis C virus infection in the last few years have led to the development of direct-acting…

Due to its increasing prevalence, exceeding 25% of the Western population, non-alcoholic fatty liver disease (NAFLD) merits recognition as one of the…

Summary of Presentations from the H. Lundbeck A/S-Supported Symposium, held at the 49th Annual International Liver Congress, London, United Kingdom…

After genotype 1 (GT1), genotype 3 (GT3) is the second most common hepatitis C virus (HCV) genotype worldwide, with an estimated worldwide prevalence of…

Acute-on-chronic liver failure (ACLF) is an entity used to define patients with liver cirrhosis presenting with acute decompensation.

Inborn errors of metabolism (IEMs) are a vast, diverse, and heterogeneous set of genetic disorders. Hepatic-based IEMs are a significant cause of…

Metabolic syndrome (MetS) represents an emerging disease in the paediatric population; it is characterised by a cluster of cardiometabolic abnormalities…

Paediatric metabolic disorders with the most clinical manifestations of deranged hepatic metabolism are discussed. The conditions which will be stressed…

Occult hepatitis B virus infection (OBI) is a challenging clinical entity. It is defined as the presence of viral DNA in the liver or serum of subjects…

Occult hepatitis B virus infection (OBI) is characterised by the persistence of hepatitis B virus (HBV) genome in the liver…

The syndrome of hepatic cirrhosis diabetes and skin pigmentation (‘Bronze diabetes’) has been well documented, including its propensity to lead to…

Acute (fulminant) liver failure (ALF) is a rare but devastating clinical condition resulting in massive hepatocyte cell death.

Acute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF…

Despite progress in understanding the underlying mechanisms, acute liver failure (ALF) is still one of the major clinical challenges in hepatology.

Liver transplantation for alcoholic liver disease (ALD) is controversially discussed. Although overall survival after liver transplantation is similar to…

Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.

The hepatitis B virus (HBV) causes infection in the liver that can lead to cirrhosis, liver cancer, and premature death. The disease is not widely…

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the…

Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children.

Alternatives for liver transplantation in severe liver disease are urgently needed in view of the limited availability of donor livers.

This Bristol Myers Squibb-sponsored symposium was chaired by Mark Thursz, who oversaw a novel news bulletin-themed symposium with sessions provided by a …

This Gilead-sponsored satellite symposium addressed the new and exciting advent of novel therapy in the field of hepatitis C by highlighting recent…